Europe
The company warns that pumps made before 2008 may display an error message that could stop the pump from working.
Sanofi said the analysis showed more cases of severe disease could occur following vaccination in patients who had not been previously infected by the dengue virus.
Today, Janssen Biotech announced it had exercised its option to enter into a collaboration deal with Idorsia to jointly develop and market aprocitentan and any derivative compounds.
Sanofi terminated an experimental Clostridium difficile vaccine after an Independent Data Monitoring Committee concluded the Phase III trial was unlikely to hit its endpoints.
Siemens Healthineers, the German industrial conglomerate’s largest and most profitable division, is worth roughly $47.49 billion.
Speculation has increased that Amazon might enter the pharmacy market after it conducted high-level talks with generic drug companies Mylan and Sandoz, a division of Novartis.
The spike began after the six-person company announced it had entered into a multi-year services agreement with Merck KGaA.
Astellas is pulling the trigger on an acquisition option from a partnership deal the two companies formed in 2013.
An IDMC told Bayer that it should unblind its Phase III clinical trial in prostate cancer in order to further analyze an increased number of fractures and deaths.
Clinical and now lab data suggest that many cancers with defective DNA repair appear to be highly sensitive to immune surveillance, including when the immune system is modified with agents that disrupt immune “checkpoints”.
PRESS RELEASES